Gene therapies to treat rheumatoid arthritis have evolved slowly, but one is ready to move into human trials and an ...

Johnson & Johnson is contributing $1 million to support the development of curricula and modernization of training and lab ...

A gene-editing therapy for sickle cell disease, with a price tag of £1.65m, is to be offered to patients on the NHS in ...

NHS patients with sickle cell disease will be able to benefit from a groundbreaking gene-editing treatment that offers the prospect of a cure for the condition. The one-off gene therapy, known as ...

CDMO Rentschler Biopharma is signalling its intent to cut down cell and gene therapy operations by shutting down its UK ...

President Trump signed an executive order on the day of his inauguration that created doubts about the future of a program ...

Solvias, a global provider of chemistry, manufacturing, and control (CMC) analytics and headquartered in Switzerland, ...

A new gene editing treatment has been approved for use in the NHS, which will help treat sickle cell disease patients ...

Britain's National Health Service (NHS) will provide a cutting-edge gene therapy that aims to cure sickle cell disease, the ...

In this webinar, sponsored by IPG Health, we will explore the role that cell and gene therapies can play in treating rare ...

People in England to benefit from groundbreaking one-off gene therapy for severe sickle cell disease approved by NICE ...

The majority are in the very early preclinical stage of development, but applications for regulatory approval have been ...